Status:

COMPLETED

Trial of Vitamin D Supplementation in Chronic Obstructive Pulmonary Disease

Lead Sponsor:

Barts & The London NHS Trust

Collaborating Sponsors:

National Health Service, United Kingdom

Conditions:

Chronic Obstructive Pulmonary Disease

Eligibility:

All Genders

40+ years

Phase:

PHASE2

PHASE3

Brief Summary

The study null hypothesis is that vitamin D supplementation will not influence time to upper respiratory tract infection or time to moderate/severe exacerbation of chronic obstructive pulmonary diseas...

Eligibility Criteria

Inclusion

  • Principal
  • Medical record diagnosis of COPD, emphysema or bronchitis
  • Post-bronchodilator FEV1 / FVC \< 70% or post-bronchodilator FEV1 / slow VC \< 70%
  • Post-bronchodilator FEV1 \< 80% predicted
  • Age ≥ 40 years on day of first dose of IMP
  • Smoking history ≥ 15 pack-years
  • If a woman of child-bearing potential, is sexually abstinent or has negative pregnancy test within 7 days of recruitment and agrees to use reliable form of contraception until she has completed the study
  • Able to give written informed consent to participate

Exclusion

  • Current diagnosis of asthma
  • Known clinically significant bronchiectasis
  • Known sarcoidosis, hyperparathyroidism, nephrolithiasis, active tuberculosis, vitamin D intolerance, liver failure, renal failure, terminal illness, lymphoma or other malignancy not in remission for ≥ 3 years
  • Taking benzothiadiazine derivative, cardiac glycoside, carbamazepine, phenobarbital, phenytoin or primidone
  • Taking dietary supplement or topical preparation containing vitamin D up to 2 months before first dose of IMP
  • Treatment with any investigational medical product or device up to 4 months before first dose of IMP
  • Breastfeeding, pregnant or planning a pregnancy
  • Baseline corrected serum calcium \> 2.65 mmol/L
  • Baseline serum creatinine \> 125 micromol/L

Key Trial Info

Start Date :

September 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2013

Estimated Enrollment :

240 Patients enrolled

Trial Details

Trial ID

NCT00977873

Start Date

September 1 2009

End Date

July 1 2013

Last Update

February 4 2014

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Lower Clapton Health Centre

London, United Kingdom, E5 0PD

2

Homerton University Hospital NHS Foundation Trust

London, United Kingdom, E9 6SR

3

Guy's and St Thomas' NHS Foundation Trust

London, United Kingdom, SE1

4

Barts and The London NHS Trust

London, United Kingdom